Suchbegriffe: HEART FAILURE - EPIDEMIOLOGY , . Treffer: 27
Sokolski, M; Trenson, S; Sokolska, JM; D'Amario, D; Meyer, P; Poku, NK; Biering-Sørensen, T; Højbjerg, Lassen, MC; Skaarup, KG; Barge-Caballero, E; Pouleur, AC; Stolfo, D; Sinagra, G; Ablasser, K; Muster, V; Rainer, PP; Wallner, M; Chiodini, A; Heiniger, PS; Mikulicic, F; Schwaiger, J; Winnik, S; Cakmak, HA; Gaudenzi, M; Mapelli, M; Mattavelli, I; Paul, M; Cabac-Pogorevici, I; Bouleti, C; Lilliu, M; Minoia, C; Dauw, J; Costa, J; Celik, A; Mewton, N; Montenegro, CEL; Matsue, Y; Loncar, G; Marchel, M; Bechlioulis, A; Michalis, L; Dörr, M; Prihadi, E; Schoenrath, F; Messroghli, DR; Mullens, W; Lund, LH; Rosano, GMC; Ponikowski, P; Ruschitzka, F; Flammer, AJ
Heart failure in COVID-19: the multicentre, multinational PCHF-COVICAV registry.
ESC Heart Fail. 2021; 8(6):4955-4967
Doi: 10.1002/ehf2.13549
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Aziz, F; Reichardt, B; Sourij, C; Dimai, HP; Reichart, D; Köhler, G; Brodmann, M; Sourij, H
Epidemiology of major lower extremity amputations in individuals with diabetes in Austria, 2014-2017: A retrospective analysis of health insurance database.
Diabetes Res Clin Pract. 2020; 170:108477
Doi: 10.1016/j.diabres.2020.108477
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Pratley, RE; Husain, M; Lingvay, I; Pieber, TR; Mark, T; Saevereid, HA; Møller, DV; Zinman, B; DEVOTE Study Group
Heart failure with insulin degludec versus glargine U100 in patients with type 2 diabetes at high risk of cardiovascular disease: DEVOTE 14.
Cardiovasc Diabetol. 2019; 18(1):156-156
Doi: 10.1186/s12933-019-0960-8
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Wiviott, SD; Raz, I; Bonaca, MP; Mosenzon, O; Kato, ET; Cahn, A; Silverman, MG; Zelniker, TA; Kuder, JF; Murphy, SA; Bhatt, DL; Leiter, LA; McGuire, DK; Wilding, JPH; Ruff, CT; Gause-Nilsson, IAM; Fredriksson, M; Johansson, PA; Langkilde, AM; Sabatine, MS; DECLARE–TIMI 58 Investigators
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes.
N Engl J Med. 2019; 380(4): 347-357.
Doi: 10.1056/NEJMoa1812389
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Hundeshagen, G; Wurzer, P; Forbes, AA; Voigt, CD; Collins, VN; Cambiaso-Daniel, J; Finnerty, CC; Herndon, DN; Branski, LK
The occurrence of single and multiple organ dysfunction in pediatric electrical versus other thermal burns.
J Trauma Acute Care Surg. 2017; 82(5):946-951
Doi: 10.1097/TA.0000000000001356
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Pölzl, G; Altenberger, J; Baholli, L; Beltrán, P; Borbély, A; Comin-Colet, J; Delgado, JF; Fedele, F; Fontana, A; Fruhwald, F; Giamouzis, G; Giannakoulas, G; Garcia-González, MJ; Gustafsson, F; Kaikkonen, K; Kivikko, M; Kubica, J; von Lewinski, D; Löfman, I; Malfatto, G; Manito, N; Martínez-Sellés, M; Masip, J; Merkely, B; Morandi, F; Mølgaard, H; Oliva, F; Pantev, E; Papp, Z; Perna, GP; Pfister, R; Piazza, V; Bover, R; Rangel-Sousa, D; Recio-Mayoral, A; Reinecke, A; Rieth, A; Sarapohja, T; Schmidt, G; Seidel, M; Störk, S; Vrtovec, B; Wikström, G; Yerly, P; Pollesello, P
Repetitive use of levosimendan in advanced heart failure: need for stronger evidence in a field in dire need of a useful therapy.
Int J Cardiol. 2017; 243(3):389-395
Doi: 10.1016/j.ijcard.2017.05.081
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Catena, C; Colussi, G; Verheyen, ND; Novello, M; Fagotto, V; Soardo, G; Sechi, LA
Moderate Alcohol Consumption Is Associated With Left Ventricular Diastolic Dysfunction in Nonalcoholic Hypertensive Patients.
Hypertension. 2016; 68(5):1208-1216
Doi: 10.1161/HYPERTENSIONAHA.116.08145
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Crespo-Leiro, MG; Anker, SD; Maggioni, AP; Coats, AJ; Filippatos, G; Ruschitzka, F; Ferrari, R; Piepoli, MF; Delgado Jimenez, JF; Metra, M; Fonseca, C; Hradec, J; Amir, O; Logeart, D; Dahlström, U; Merkely, B; Drozdz, J; Goncalvesova, E; Hassanein, M; Chioncel, O; Lainscak, M; Seferovic, PM; Tousoulis, D; Kavoliuniene, A; Fruhwald, F; Fazlibegovic, E; Temizhan, A; Gatzov, P; Erglis, A; Laroche, C; Mebazaa, A; Heart Failure Association (HFA) of the European Society of Cardiology (ESC)
European Society of Cardiology Heart Failure Long-Term Registry (ESC-HF-LT): 1-year follow-up outcomes and differences across regions.
Eur J Heart Fail. 2016; 18(6):613-625
Doi: 10.1002/ejhf.566
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Jordan, J; Toplak, H; Grassi, G; Yumuk, V; Kotsis, V; Engeli, S; Cuspidi, C; Nilsson, PM; Finer, N; Doehner, W
Joint statement of the European Association for the Study of Obesity and the European Society of Hypertension: obesity and heart failure.
J Hypertens. 2016; 34(9):1678-1688
Doi: 10.1097/HJH.0000000000001013
Web of Science
PubMed
FullText
FullText_MUG
Marso, SP; McGuire, DK; Zinman, B; Poulter, NR; Emerson, SS; Pieber, TR; Pratley, RE; Haahr, PM; Lange, M; Frandsen, KB; Rabøl, R; Buse, JB
Design of DEVOTE (Trial Comparing Cardiovascular Safety of Insulin Degludec vs Insulin Glargine in Patients With Type 2 Diabetes at High Risk of Cardiovascular Events) - DEVOTE 1.
Am Heart J. 2016; 179(19-20):175-183
Doi: 10.1016/j.ahj.2016.06.004
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Kleber, ME; Koller, L; Goliasch, G; Sulzgruber, P; Scharnagl, H; Silbernagel, G; Grammer, TB; Delgado, G; Tomaschitz, A; Pilz, S; März, W; Niessner, A
Von Willebrand factor improves risk prediction in addition to N-terminal pro-B-type natriuretic peptide in patients referred to coronary angiography and signs and symptoms of heart failure and preserved ejection fraction.
Circ Heart Fail. 2015; 8(1):25-32
Doi: 10.1161/CIRCHEARTFAILURE.114.001478
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Lip, GY; Heinzel, FR; Gaita, F; Juanatey, JR; Le Heuzey, JY; Potpara, T; Svendsen, JH; Vos, MA; Anker, SD; Coats, AJ; Haverkamp, W; Manolis, AS; Chung, MK; Sanders, P; Pieske, B
European Heart Rhythm Association/Heart Failure Association joint consensus document on arrhythmias in heart failure, endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society.
Eur J Heart Fail. 2015; 17(9):848-874
Doi: 10.1002/ejhf.338
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Gori, M; Lam, CS; Gupta, DK; Santos, AB; Cheng, S; Shah, AM; Claggett, B; Zile, MR; Kraigher-Krainer, E; Pieske, B; Voors, AA; Packer, M; Bransford, T; Lefkowitz, M; McMurray, JJ; Solomon, SD; PARAMOUNT Investigators
Sex-specific cardiovascular structure and function in heart failure with preserved ejection fraction.
Eur J Heart Fail. 2014; 16(5):535-542
Doi: 10.1002/ejhf.67
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Kraigher-Krainer, E; Lyass, A; Massaro, JM; Lee, DS; Ho, JE; Levy, D; Kannel, WB; Vasan, RS
Association of physical activity and heart failure with preserved vs. reduced ejection fraction in the elderly: the Framingham Heart Study.
Eur J Heart Fail. 2013; 15(7):742-746
Doi: 10.1093/eurjhf/hft025
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Gary, T; Belaj, K; Hafner, F; Hackl, G; Froehlich, H; Pilger, E; Brodmann, M
A high CHA(2)DS(2)-VASc score is associated with a high risk for critical limb ischemia in peripheral arterial occlusive disease patients.
Atherosclerosis. 2012; 225(2):517-520
Doi: 10.1016/j.atherosclerosis.2012.10.025
Web of Science
PubMed
FullText
FullText_MUG
Grünig, E; Ehlken, N; Ghofrani, A; Staehler, G; Meyer, FJ; Juenger, J; Opitz, CF; Klose, H; Wilkens, H; Rosenkranz, S; Olschewski, H; Halank, M
Effect of exercise and respiratory training on clinical progression and survival in patients with severe chronic pulmonary hypertension.
Respiration. 2011; 81(5):394-401
Doi: 10.1159/000322475
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Lam, CSP; Donal, E; Kraigher-Krainer, E; Vasan, RS
Epidemiology and clinical course of heart failure with preserved ejection fraction.
Eur J Heart Fail. 2011; 13(1):18-28
Doi: 10.1093/eurjhf/hfq121
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Lam, CSP; Lyass, A; Kraigher-Krainer, E; Massaro, JM; Lee, DS; Ho, JE; Levy, D; Redfield, MM; Pieske, BM; Benjamin, EJ; Vasan, RS
Cardiac dysfunction and noncardiac dysfunction as precursors of heart failure with reduced and preserved ejection fraction in the community.
Circulation. 2011; 124(1):24-30
Doi: 10.1161/CIRCULATIONAHA.110.979203
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Pieske, B
Heart failure with preserved ejection fraction-a growing epidemic or 'The Emperor's New Clothes?'
EUR J HEART FAIL. 2011; 13(1): 11-13.
Doi: 10.1093/eurjhf/hfq215
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Kamp, O; Metra, M; De Keulenaer, GW; Pieske, B; Conraads, V; Zamorano, J; Huysse, L; Vardas, PE; Bohm, M; Cas, LD
Effect of the long-term administration of nebivolol on clinical symptoms, exercise capacity and left ventricular function in patients with heart failure and preserved left ventricular ejection fraction: background, aims and design of the ELANDD study.
Clin Res Cardiol. 2010; 99(2):75-82
Doi: 10.1007/s00392-009-0098-x
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Maggioni, AP; Dahlström, U; Filippatos, G; Chioncel, O; Leiro, MC; Drozdz, J; Fruhwald, F; Gullestad, L; Logeart, D; Metra, M; Parissis, J; Persson, H; Ponikowski, P; Rauchhaus, M; Voors, A; Nielsen, OW; Zannad, F; Tavazzi, L; on behalf of the Heart Failure Association of the ESC (HFA)
EURObservational Research Programme: the Heart Failure Pilot Survey (ESC-HF Pilot).
Eur J Heart Fail. 2010; 12(10): 1076-1084.
Doi: 10.1093/eurjhf/hfq154
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Mehrhof, F; Löffler, M; Gelbrich, G; Ozcelik, C; Posch, M; Hense, HW; Keil, U; Scheffold, T; Schunkert, H; Angermann, C; Ertl, G; Jahns, R; Pieske, B; Wachter, R; Edelmann, F; Wollert, KC; Maisch, B; Pankuweit, S; Erbel, R; Neumann, T; Herzog, W; Katus, H; Müller-Tasch, T; Zugck, C; Düngen, HD; Regitz-Zagrosek, V; Lehmkuhl, E; Störk, S; Siebert, U; Wasem, J; Neumann, A; Göhler, A; Anker, SD; Köhler, F; Möckel, M; Osterziel, KJ; Dietz, R; Rauchhaus, M; Competence Network Heart Failure
A network against failing hearts--introducing the German "Competence Network Heart Failure".
Int J Cardiol. 2010; 145(1):135-138
Doi: 10.1016/j.ijcard.2009.06.061
Web of Science
PubMed
FullText
FullText_MUG
Hoeper, MM; Barbera, JA; Channick, RN; Hassoun, PM; Lang, IM; Manes, A; Martinez, FJ; Naeije, R; Olschewski, H; Pepke-Zaba, J; Redfield, MM; Robbins, IM; Souza, R; Torbicki, A; McGoon, M
Diagnosis, assessment, and treatment of non-pulmonary arterial hypertension pulmonary hypertension.
J AMER COLL CARDIOL. 2009; 54(1 Suppl): S85-S96.
Doi: 10.1016/j.jacc.2009.04.008
[Oral Communication]
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Yusuf, S; Diener, HC; Sacco, RL; Cotton, D; Ounpuu, S; Lawton, WA; Palesch, Y; Martin, RH; Albers, GW; Bath, P; Bornstein, N; Chan, BP; Chen, ST; Cunha, L; Dahlöf, B; De Keyser, J; Donnan, GA; Estol, C; Gorelick, P; Gu, V; Hermansson, K; Hilbrich, L; Kaste, M; Lu, C; Machnig, T; Pais, P; Roberts, R; Skvortsova, V; Teal, P; Toni, D; VanderMaelen, C; Voigt, T; Weber, M; Yoon, BW; PRoFESS Study Group
Telmisartan to prevent recurrent stroke and cardiovascular events.
N Engl J Med. 2008; 359(12):1225-1237
Doi: 10.1056/NEJMoa0804593
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Schmidt, AG; Pieske, B
Diastolic heart failure -- diagnostics
Dtsch Med Wochenschr. 2005; 130(19): 1208-1212.
Doi: 10.1055/s-2005-868702
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Baulmann, J; Homsi, R; Un, S; Vetter, H; Düsing, R; Mengden, T
Arterial stiffness in arterial hypertension. A new risk factor for left ventricular hypertrophy and cardiac insufficiency?].
Dtsch Med Wochenschr. 2004; 129(9):447-452
Doi: 10.1055/s-2004-820067
Web of Science
PubMed
FullText
FullText_MUG
Sametz, W; Metzler, H; Gries, M; Porta, S; Sadjak, A; Supanz, S; Juan, H
Perioperative catecholamine changes in cardiac risk patients.
Eur J Clin Invest. 1999; 29(7):582-587
Doi: 10.1046/j.1365-2362.1999.00509.x
Web of Science
PubMed
FullText
FullText_MUG